The present results suggest that multilayered crosstalk between GPCRs and EGFR may play an important role in orchestrating downstream signaling molecules that are implicated in the development of gefitinib-resistant NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.